PCI 3.06.26
Wallonia
Thermofisher: Thu 29 February 2024, 11:15

Current Edition

Upcoming Events

DDL 2026
SLAS
Bio IT
ELRIG Drug Discovery USA
Biotechnology Show 13.02.26
PFS & Injectable drug devices west coast

Advertisement

Advertisement

A&M Stabtest April 26

Advertisement

CDD Vault – 18.03.2025

Advertisement

Biopharma Group – 19th March 2025

The Impact of Data and Academic Partnerships on Cold Chain Innovation

Cold chain logistics are vital in the pharmaceutical and life sciences industries, where temperature-sensitive products such as vaccines, medications, and biological samples must be transported and stored under strict temperature controls. Ensuring the integrity of these products is essential, as their efficacy often relies on integrity. precise temperature regulation. However, managing the distribution of such sensitive goods presents significant challenges. With growing sustainability demands, the industry is increasingly relying on innovative solutions that reduce carbon emissions while upholding product integrity.

One such solution has been the collaboration between academic institutions and industry stakeholders to optimise cold chain logistics, with a growing focus on sustainability. A notable example is the partnership between Cardiff University’s Business School and Tower Cold Chain (part of Cold Chain Technologies), aimed at utilising academic expertise to enhance operational efficiency while prioritising sustainable practices.

The Environmental Challenges of Cold Chain Logistics in the Pharmaceutical Industry The pharmaceutical industry’s cold chain logistics operations are highly energy-intensive, primarily due to the stringent temperature requirements needed to preserve the efficacy of drugs and biological materials. For example, vaccines typically need to be stored between 2–8°C (35–46°F), while gene therapies and biologics may require sub-zero or even cryogenic temperatures. Maintaining these conditions over long distances and periods can be technologically challenging and environmentally costly.

Traditional cold chain solutions often involve single-use packaging and active cooling systems, which require constant electricity and result in significant waste and carbon emissions. Additionally, the need for global logistics networks exacerbates the environmental impact. The pharmaceutical sector’s increased demand for reliable cold chain logistics, particularly during emergencies like the COVID-19 pandemic, has put further strain on the industry’s environmental footprint.

Advertisement

Richter: Wed 23 October 2024, 09:03

Advertisement

Aseptic Tech

Advertisement

Steribar – 12.05.2025

Advertisement

PharmExcel

Advertisement

Polypure hompage